TrialBone marrow transplantation2008

Ibritumomab tiuxetan (Zevalin) combined with reduced-intensity conditioning and allogeneic stem-cell transplantation (SCT) in patients with chemorefractory non-Hodgkin's lymphoma.

A Shimoni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.